We are delighted that several of our affiliated companies were recognised at the 2023 Cambridge Independent Science & Technology Awards last night. Among the list of awardees was Cardiatec Biosciences, an AI drug target discovery company co-founded by Milner Head of Computational Biology & AI Namshik Han, and Storm Therapeutics, a clinical stage biotechnology company co-founded by Milner Director Tony Kouzarides.

Milner affiliates won in the following categories:

Employer of the Year
Winner: bit.bio

The One to Watch
Winner: CardiaTec Biosciences 

The Award for Innovation
Highly Commended: Enhanc3d Genomics

Biotech Company of the Year
Highly Commended: Storm Therapeutics

AI Company of the Year
Winner: Intellegens 
Highly Commended: Eagle Genomics 

Life Science Company of the Year
Winner: Astex Pharmaceuticals
Highly Commended: Cerevance 

Congratulations to all of the winners and runners up in each category. The full list of awardees can be found at the Cambridge Independent website.

Save the date for the Milner Therapeutics Symposium: 7 July 2027

X
Copy link